Apple Shares Fall 3% As Trump Threatens 25% Tariff—Sparking Market Selloff — Negative
AAPL Forbes — May 23, 2025“I have long ago informed Tim Cook of Apple that I expected their iPhones that will be sold in the [U.S.] will be manufactured and built in the [U.S.], not India, or anyplace else,” Trump wrote, adding, “If that is not the case, a tariff of at least 25% must be paid by Apple to the U.S.”

CIVI Investors Have the Opportunity to Lead the Civitas Resources Securities Fraud Lawsuit with Faruqi & Faruqi, LLP — Neutral
CIVI GlobeNewsWire — May 23, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Civitas To Contact Him Directly To Discuss Their Options

ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP — Neutral
ZBIO GlobeNewsWire — May 23, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zenas To Contact Him Directly To Discuss Their Options.

ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
ZBIO PRNewsWire — May 23, 2025LOS ANGELES , May 23, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zenas BioPharma, Inc. ("Zenas" or "the Company") (NASDAQ: ZBIO) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025.

CGC Investors Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit with the Schall Law Firm — Neutral
CGC PRNewsWire — May 23, 2025LOS ANGELES , May 23, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Canopy Growth Corporation ("Canopy Growth" or "the Company") (NASDAQ: CGC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 30, 2024 and February 6, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 3, 2025.

Intuit shares jump after earnings, outlook top Wall Street views — Positive
INTU Proactive Investors — May 23, 2025Shares of Intuit Inc (NASDAQ:INTU, ETR:ITU) climbed over 9% on Friday morning after the financial software maker reported stronger-than-expected quarterly earnings and lifted its full-year guidance, fueled by robust gains in its tax and credit segments. The maker of TurboTax and QuickBooks posted fiscal third-quarter revenue of $7.88 billion, beating analysts' average estimate of $7.56 billion, according to LSEG data.

Apple is reportedly looking to release a pair of smart glasses by the end of next year in a bid to compete with Meta's AI-powered glasses, the Ray-Ban Meta.

SOUN Investors Have Opportunity to Lead SoundHound AI, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
SOUN PRNewsWire — May 23, 2025LOS ANGELES , May 23, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SoundHound AI, Inc. ("SoundHound" or "the Company") (NASDAQ: SOUN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2024 and March 3, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 27, 2025.

Comprehensive AI Strategy Aids Palantir, Overvaluation Raises Concern — Negative
PLTR Zacks Investment Research — May 23, 2025PLTR's AI push and strong balance sheet impress, but concerns linger over the stock's valuation despite growing commercial traction.

Recurring Revenue Business Model Aids BR Amid High Competition — Neutral
BR Zacks Investment Research — May 23, 2025Broadridge Financial Solutions leans on strong recurring revenues and rising dividends.

Kohl's Q1 Earnings Coming Up: What Investors Need to Understand — Negative
KSS Zacks Investment Research — May 23, 2025KSS is expected to report lower Q1 revenues and a loss due to sluggish home sales and ongoing macroeconomic headwinds.

IBTA Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - IBTA — Neutral
IBTA PRNewsWire — May 23, 2025LOS ANGELES , May 23, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Ibotta, Inc. ("Ibotta" or "the Company") (NYSE: IBTA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IBTA Investors Have Opportunity to Lead Ibotta, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
IBTA PRNewsWire — May 23, 2025LOS ANGELES , May 23, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ibotta, Inc. ("Ibotta" or "the Company") (NYSE: IBTA) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on April 18, 2024, are encouraged to contact the firm before June 16, 2025.

SEI Investors Have Opportunity to Lead Solaris Energy Infrastructure, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
SEI PRNewsWire — May 23, 2025LOS ANGELES , May 23, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Solaris Energy Infrastructure, Inc. ("Solaris" or "the Company") (NYSE: SEI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 9, 2024 and March 17, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 27, 2025.

HPQ Gears Up to Report Q2 Earnings: What's in Store for the Stock? — Positive
HPQ Zacks Investment Research — May 23, 2025HP's Q2 results are likely to reflect benefits from traction in its AI-based computing and latest gaming products.

DuPont Launches AmberChrom TQ1 Resin for Biopharma Applications — Positive
DD Zacks Investment Research — May 23, 2025DD launches AmberChrom TQ1 resin, boosting oligonucleotide and peptide purification with high capacity, purity, and scalability.

Nvidia (NVDA) earnings will take center stage next week. Despite recent negative headlines impacting its China business, Shay Boloor says NVDA is in prime position as the A.I.

Markets Sell Off & VIX Explodes on E.U., AAPL Tariff Threats — Negative
AAPL Schwab Network — May 23, 2025The tariff talk is back. President Trump threatened 50% tariffs against the E.U.

ASML: Want To Win The AI Trade? Start With The Shovels And Pans — Positive
ASML Seeking Alpha — May 23, 2025ASML is the unrivaled infrastructure play for the AI boom, holding a monopoly on EUV lithography essential to all advanced chips. Decades of R&D and massive barriers to entry give ASML a Buffett-style 'moat with sharks,' ensuring its dominance and technological lead. Despite regulatory risks and export controls, ASML's projected high-teens EPS growth and rapid dividend increases make it a compelling long-term investment.

Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy — Neutral
CI Business Wire — May 23, 2025ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)-- #kerecis--Cigna Insurance Company now includes Kerecis products in its medical coverage policy for the treatment of diabetic foot ulcers.
